Shan Wu
Corporate Officer/Principal bij VIRIDIAN THERAPEUTICS, INC.
Profiel
Shan Wu is currently the Chief Business Officer at Viridian Therapeutics, Inc. Prior to this role, she served as the Vice President & Head of Business Development at Magenta Therapeutics, Inc. from 2021 to 2023.
Dr. Wu completed her undergraduate degree at the University of Virginia and holds a doctorate from the Massachusetts Institute of Technology.
Actieve functies van Shan Wu
| Bedrijven | Functie | Begin |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Corporate Officer/Principal | 30-10-2023 |
Eerdere bekende functies van Shan Wu
| Bedrijven | Functie | Einde |
|---|---|---|
| MAGENTA THERAPEUTICS | Investor Relations Contact | 01-09-2023 |
Opleiding van Shan Wu
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Virginia | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
